VBIO — Valion Bio, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1787740 ·
Last close
$2.21
Market Cap
$1.96M
52W High
$78.75
52W Low
$2.05
ADV30
2,400,990
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -6,424,000 | -7,103,000 | 32,473,000 | 2,108,000 | 28,227,000 |
| Mar 2026 | 0 | — | -5,634,000 | -6,202,000 | 38,215,000 | 7,215,000 | 27,153,000 |
| Dec 2025 | -302,000 | — | -1,975,000 | -2,849,000 | 31,607,000 | 12,645,000 | 14,810,000 |
| Sep 2025 | 146,000 | -145,000 | -2,483,000 | -2,596,000 | 6,229,000 | 3,450,000 | 638,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-10,837,000
Investing CF
$-186,000
Financing CF
$18,221,000
CapEx
$-62,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-8.91
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-59,034,000
Inventory
$750,000
Receivables
$19,000
ST Investments
—
EBIT TTM
$-11,918,000
Pretax Income TTM
$-12,716,000
Interest Exp TTM
$648,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$-86,000
EBITDA
$-16,536,000
Free Cash Flow
$-8,062,250
Enterprise Value
$17,306,954
Total Cash
$2,108,000
Total Debt
$17,409,000
Shares Out
887,589
Trailing EPS
$-184.45
Book Value
$1.02
ROE
-459.5%
ROA
-57.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -7,898,000 | -8,878,000 | 31,607,000 | 14,810,000 | 16,797,000 | -6,999,000 |
| Dec 2024 | 0 | -4,476,000 | -5,655,000 | 2,810,000 | 272,000 | 2,535,000 | -5,725,000 |
| Dec 2023 | 1,176,000 | -8,245,000 | -8,244,000 | 5,160,000 | 1,577,000 | 3,580,000 | -8,511,000 |
| Dec 2022 | 1,840,000 | -10,098,000 | -10,096,000 | 5,880,000 | 2,245,000 | 3,630,000 | -8,919,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$-23,000
NetIncome TTM
$-13,578,000
OpCashFlow TTM
—
Assets (Latest)
$38,215,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TCRT | Alaunos Therapeutics, Inc. | $1.98M | $0.78 | — |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | $1.88M | $0.79 | — |
| ARTL | ARTELO BIOSCIENCES, INC. | $1.85M | $3.37 | — |
| ISCO | International Stem Cell CORP | $2.09M | $0.26 | — |
| OGEN | ORAGENICS INC | $2.09M | $0.46 | — |
News headlines (Yahoo Finance, 1h cache)
Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand
2026-10-09 11:45 · Yahoo
Valion Bio Completes Oral Mucosal Entolimod Formulation, Opening Potential Needle-Free Development Pathway
2026-09-30 14:41 · Yahoo
Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity
2026-09-30 11:45 · Yahoo
Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
2026-09-23 12:00 · Yahoo
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
2026-09-22 12:00 · Yahoo
Valion Bio Announces Reverse Stock Split
2026-08-27 12:30 · Yahoo
Valion Bio Advances Government-Funded Entolimod Radiation Injury Studies With Data Expected in Early Fall
2026-08-12 14:17 · Yahoo
World-Premier Cancer Center Sheba Medical Center Selects Entolimod for Clinical Trial, Potentially Expanding Valion Bio into the Multi-Billion-Dollar Neutropenia Market
2026-07-20 17:05 · Yahoo
Valion Bio Advances Integrated Biodefense and Immunology Platform Through Continued Government Engagement, Domestic Manufacturing and Oncology Expansion
2026-07-14 11:45 · Yahoo
AFRRI/NIAID Designs Proprietary PBI-BM2.5 Protocol to Evaluate Valion Bio's (NASDAQ: VBIO) Entolimod as the First and Only Treatment for GI-ARS
2026-06-25 11:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.